ENTITY

Turning Point Therapeutics I (TPTX US)

1
Analysis
Health CareUnited States
Turning Point Therapeutics, Inc. operates as a biopharmaceutical company. The Company designs and develops novel small molecule to treat cancer related diseases. Turning Point Therapeutics serves medical sector in the United States.
more
Refresh
bearishS&P 500 INDEX
20 May 2020 07:34

U.S. Equity Strategy: Round Trip Back To Resistance

Our base case continues to be for near-term consolidation while the market determines the implications of states’ reopening (i.e., the...

Logo
195 Views
Share
No more insights
x